These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26338675)
1. Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders. Sala C; Vicidomini C; Bigi I; Mossa A; Verpelli C J Neurochem; 2015 Dec; 135(5):849-58. PubMed ID: 26338675 [TBL] [Abstract][Full Text] [Related]
2. The emerging role of SHANK genes in neuropsychiatric disorders. Guilmatre A; Huguet G; Delorme R; Bourgeron T Dev Neurobiol; 2014 Feb; 74(2):113-22. PubMed ID: 24124131 [TBL] [Abstract][Full Text] [Related]
3. A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders. Grabrucker AM Dev Neurobiol; 2014 Feb; 74(2):136-46. PubMed ID: 23650259 [TBL] [Abstract][Full Text] [Related]
11. Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies. Sarowar T; Grabrucker AM Neural Plast; 2016; 2016():8051861. PubMed ID: 27795858 [TBL] [Abstract][Full Text] [Related]
12. Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice. Vyas Y; Lee K; Jung Y; Montgomery JM Mol Brain; 2020 Aug; 13(1):110. PubMed ID: 32758248 [TBL] [Abstract][Full Text] [Related]
13. Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries. Wan L; Liu D; Xiao WB; Zhang BX; Yan XX; Luo ZH; Xiao B Cell Mol Neurobiol; 2022 Aug; 42(6):1623-1643. PubMed ID: 33595806 [TBL] [Abstract][Full Text] [Related]
14. Structural deficits in key domains of Shank2 lead to alterations in postsynaptic nanoclusters and to a neurodevelopmental disorder in humans. Hassani Nia F; Woike D; Bento I; Niebling S; Tibbe D; Schulz K; Hirnet D; Skiba M; Hönck HH; Veith K; Günther C; Scholz T; Bierhals T; Driemeyer J; Bend R; Failla AV; Lohr C; Alai MG; Kreienkamp HJ Mol Psychiatry; 2024 Jun; 29(6):1683-1697. PubMed ID: 36450866 [TBL] [Abstract][Full Text] [Related]
15. [Role of NRXN-NLGN-SHANK pathway gene variations in the pathogenesis of autism spectrum disorders]. He L; Liu X; Song Y; Tang Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):753-756. PubMed ID: 30298512 [TBL] [Abstract][Full Text] [Related]
16. Shankopathies in the Developing Brain in Autism Spectrum Disorders. Vyas Y; Cheyne JE; Lee K; Jung Y; Cheung PY; Montgomery JM Front Neurosci; 2021; 15():775431. PubMed ID: 35002604 [TBL] [Abstract][Full Text] [Related]
17. SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region. Mameza MG; Dvoretskova E; Bamann M; Hönck HH; Güler T; Boeckers TM; Schoen M; Verpelli C; Sala C; Barsukov I; Dityatev A; Kreienkamp HJ J Biol Chem; 2013 Sep; 288(37):26697-708. PubMed ID: 23897824 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches for shankopathies. Wang X; Bey AL; Chung L; Krystal AD; Jiang YH Dev Neurobiol; 2014 Feb; 74(2):123-35. PubMed ID: 23536326 [TBL] [Abstract][Full Text] [Related]
19. Shank postsynaptic scaffolding proteins in autism spectrum disorder: Mouse models and their dysfunctions in behaviors, synapses, and molecules. Jung S; Park M Pharmacol Res; 2022 Aug; 182():106340. PubMed ID: 35792298 [TBL] [Abstract][Full Text] [Related]
20. Neurodevelopmental disorder-associated ZBTB20 gene variants affect dendritic and synaptic structure. Jones KA; Luo Y; Dukes-Rimsky L; Srivastava DP; Koul-Tewari R; Russell TA; Shapiro LP; Srivastava AK; Penzes P PLoS One; 2018; 13(10):e0203760. PubMed ID: 30281617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]